Editorial Board — Medscape Psychiatry & Mental Health

Board Members

  • Leslie Citrome, MD, MPH
    • NYU School of Medicine
      New York, NY
      Nathan S Kline Institute for Psychiatric Research and Rockland Psychiatric Center
      Orangeburg, New York
  • Christoph U. Correll, MD
    • Hofstra North Shore LIJ School of Medicine
      Hempstead, New York
      The Zucker Hillside Hospital
      Glen Oaks, New York
  • Robert L. Findling, MD
    • Case Western Reserve University
      Cleveland, Ohio
  • Bradley Gaynes, MD, MPH
    • University of North Carolina School of Medicine
      Chapel Hill, North Carolina
  • Joseph F. Goldberg, MD
    • Mount Sinai School of Medicine
      New Rochelle, NY
      Silver Hill Hospital
      Norwalk, Connecticut
 

Board Member Details

Leslie Citrome, MD, MPH
Leslie Citrome, MD, MPH

Professor, Department of Psychiatry, NYU School of Medicine, New York, New York; Attending Physician, Good Samaritan Hospital, Suffern, New York

Leslie Citrome, MD, MPH, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Eli Lilly and Company; Janssen Pharmaceutica Products, L.P. (US); Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Sunovion; Valeant Pharmaceuticals
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Eli Lilly and Company; Merck & Co., Inc.; Pfizer Inc.; Sunovion Received research grants from: AstraZeneca Pharmaceuticals LP; Pfizer Inc.
Received income in an amount equal to or greater than $250 from: AstraZeneca Pharmaceuticals LP; Eli Lilly and Company; Janssen Pharmaceutica Products, L.P. (US); Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Sunovion; Valeant Pharmaceuticals

[ Back to Top ]
Christoph U. Correll, MD
Christoph U. Correll, MD

Associate Professor of Psychiatry and Behavioral Sciences, Department of Psychiatry, Albert Einstein College of Medicine, Bronx, NY; Medical Director, Recognition and Prevention Program, Department of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, New York

Christopher U. Correll, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Actelion Pharmaceuticals, Ltd; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Cephalon, Inc.; Eli Lilly and Company; Janssen Pharmaceutica Products, L.P.; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; GlaxoSmithKline; F. Hoffmann-La Roche Ltd; Medicure; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; Schering-Plough Corporation; Supernus; Takeda Pharmaceuticals North America, Inc.; Vanda Pharmaceuticals Inc.
Served as a Data Safety Monitoring Board Member for: Bristol-Myers Squibb Company; Cephalon, Inc.; Otsuka Pharmaceutical Co., Ltd.; Supernus

[ Back to Top ]
Robert L. Findling, MD
Robert L. Findling, MD

Professor of Psychiatry and Pediatrics, Case Western Reserve University; Director, Child & Adolescent Psychiatry, University Hospitals Case Medical Center, Cleveland, Ohio

Robert L. Findling, MD, has disclosed the following relevant financial relationships:
Served as a consultant for: Abbott Laboratories; Addrenex; AstraZeneca Pharmaceuticals LP; Biovail Corporation; Bristol-Myers Squibb Company; Forest Laboratories, Inc; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; KemPharm; Eli Lilly and Company; Lundbeck Research USA, Inc; Novartis Pharmaceuticals Corporation; Noven; Organon Pharmaceuticals USA Inc; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; sanofi-aventis; Schering-Plough; Seaside Therapeutics; Sepracor Inc.; Shire; Solvay Pharmaceuticals, Inc.; Sunovion; Supernus Pharmaceuticals; Validus; Wyeth Pharmaceuticals Inc.
Served as a speaker or a member of a speakers bureau for: Bristol-Myers Squibb Company; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Shire Received grants for clinical research from: Abbott Laboratories; Addrenex; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Forest Laboratories Inc; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C; Eli Lilly and Company; Neuropharm; Otsuka Pharmaceuticals Co., Ltd; Pfizer Inc.; Rhodes Pharmaceuticals; Schering-Plough; Shire; Supernus Pharmaceuticals; Wyeth Pharmaceuticals Inc.

[ Back to Top ]
Bradley Gaynes, MD, MPH
Bradley Gaynes, MD, MPH

Professor, Department of Psychiatry, Associate Chair of Research Training and Education, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Bradley Gaynes, MD, MPH, has disclosed no relevant financial relationships.

[ Back to Top ]
Joseph F. Goldberg, MD
Joseph F. Goldberg, MD

Associate Clinical Professor, Department of Psychiatry, Mount Sinai School of Medicine, New Rochelle, New York; Director, Affective Disorders Research Program, Silver Hill Hospital, Norwalk, Connecticut

Joseph F. Goldberg, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Dey Pharma/Mylan Inc.; Eli Lilly and Company
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Eli Lilly and Company; Dey Pharma/Mylan Inc.; Merck & Co., Inc.; Sunovion

[ Back to Top ]
Eric Hollander, MD
Eric Hollander, MD

Professor, Department of Psychiatry, Albert Einstein College of Medicine; Director, Compulsive, Impulsive, Autism Program, Montefiore Medical Center, New York, New York

Eric Hollander, MD, has disclosed the following relevant financial relationships:
Served as a consultant for: Transcept Pharmaceuticals, Inc., Roche
Received a research grant from: Forest Pharmaceuticals, Inc.

[ Back to Top ]
Scott H. Kollins, PhD
Scott H. Kollins, PhD

Associate Professor, Department of Psychiatry and Behavioral Science; Director, Duke ADHD Program, Duke University Medical Center, Durham, North Carolina

Scott H. Kollins, PhD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Shire; Otsuka Pharmaceutical Co., Ltd.; Shionogi USA, Inc.; Supernus Pharmaceuticals, Inc.; National Institutes of Health; Attention Therapeutics, Inc.
Received research grants from: Shire; Otsuka Pharmaceutical Co., Ltd.; Shionogi USA, Inc.; Supernus Pharmaceuticals, Inc.; National Institutes of Health; Rhodes Pharmaceuticals
Received income in an amount equal to or greater than $250 from: Shire; Otsuka Pharmaceutical Co., Ltd.; Shionogi USA, Inc.; Supernus Pharmaceuticals, Inc.; National Institutes of Health; Rhodes Pharmaceuticals; Attention Therapeutics, Inc.

[ Back to Top ]
Jeffrey A. Lieberman, MD
Jeffrey A. Lieberman, MD

Professor and Chairman, Department of Psychiatry, Columbia University College of Physicians and Surgeons; Psychiatrist in Chief, New York Presbyterian Hospital, New York, New York

Jeffrey A. Lieberman, MD, has disclosed the following relevant financial relationships:
Received research grants from: Allon; GlaxoSmithKline; Janssen Pharmaceutica Products, L.P. (US); Merck & Co., Inc; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Sepracor Inc.; Targacept
Served on the advisory board for: Bioline; GlaxoSmithKline; Intra-Cellular Therapies, Inc.; Eli Lilly and Company; Pierre Fabre; Psychogenics Received patents from: Repligen Corporation

[ Back to Top ]
Jon McClellan, MD
Jon McClellan, MD

Professor, Department of Psychiatry, University of Washington, Seattle, Washington; Medical Director, Child Study and Treatment Center, Lakewood, Washington

Jon McClellan, MD, has disclosed no relevant financial relationships.

[ Back to Top ]
Michael E. Thase, MD
Michael E. Thase, MD

Professor, University of Pennsylvania School of Medicine, Mood and Anxiety Disorders Treatment & Research Program, Philadelphia, Pennsylvania

Michael E. Thase, MD, has disclosed no relevant financial relationships.

[ Back to Top ]
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.